Gupta N, Martin PM, Prasad PD, Ganapathy V (2006) SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter
The lack of extensive human clinical trials means theres no officially established optimal dose
These symptoms occur because the body struggles to produce enough red blood cells
Here's the low down
On this basis, the continuous optimization and improvement of delivery systems and regulatory strategies for engineered live bacteria are expected to advance the clinical translation and therapeutic application of engineered live bacteria [230], especially in the management of liver diseases and disease related to the gut-liver axis
5 Watanabe K, Otani K, Nikaido T, Kato K, Kobayashi H, Yabuki S, Konno SI, Matsumoto Y